Inhibiting a specific protein complex in SARS-CoV-2, the virus that causes COVID-19, may be a promising therapeutic target for treating the disease, according to a Northwestern Medicine study.
The Northwestern Medicine Comprehensive COVID-19 Center is committed to caring for and conducting research on behalf of patients who experience long-term complications from COVID-19.
Feinberg is hosting the first annual Big Ten Augmented Intelligence Bowl, bringing together multi-disciplinary teams of investigators from institutions representing the Big Ten Academic Alliance to use AI to address health disparities.
A team of Northwestern Medicine investigators have discovered a set of intracellular mechanisms that support the polarized function of the skin’s outermost layer, the epidermis.
Northwestern Medicine investigators continue to assess COVID-19 treatments for mild to severe cases, the widespread adoption of telemedicine, and why a “return to normal” will be a missed opportunity to improve healthcare.
Arthur Prindle, PhD, assistant professor of Biochemistry and Molecular Genetics, has been honored with the Early Career Award for Scientists and Engineers from the U.S. Army Research Office.
Assessing and addressing the needs of women working in the life sciences may improve work-life integration and innovation, according to a recent survey.
Using small molecular inhibitors to block the BAP1 complex may be a promising targeted therapy approach for leukemia, according to a Northwestern Medicine study published in Nature Cancer.
Feinberg honored the MD Class of 2021 during the medical school’s 162nd commencement ceremony, held virtually on May 24.
A mental health smartphone app developed by a team of Northwestern Medicine investigators helped improve depressive symptoms in patients with diabetes and hypertension, according to a recent clinical trial published in JAMA.